Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
Chronic Hepatitis B Virus Infection in Zambia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.
- Status
- COMPLETED
- Phase
- NA
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
- Status
- UNKNOWN
- Phase
- PHASE2
Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
Novel Gallium Imaging in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients
- Status
- WITHDRAWN
- Phase
- N/A
Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2